<DOC>
	<DOCNO>NCT01337557</DOCNO>
	<brief_summary>The purpose study ass BEPREVE ( bepotastine besilate ophthalmic solution ) 1.5 % effect contact lens wear patient contact lens intolerance due allergic conjunctivitis .</brief_summary>
	<brief_title>Use BEPREVE ( Bepotastine Besilate Ophthalmic Solution ) 1.5 % Allergic Conjunctivitis Contact Lenses</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>History allergic conjunctivitis History contact lens intolerance Between age 18 inclusive . Males females Patient generally good &amp; stable overall health . Patient likely comply study guideline &amp; study visit . Informed consent sign . Are willing/able return require study visit . Are willing/able follow instruction study investigator his/her staff . If woman capable become pregnant , agree urine pregnancy test perform screening ( must negative ) agree use medically acceptable form birth control throughout study duration least one week prior completion study . Women consider capable become pregnant include female experience menarche experience menopause ( define amenorrhea great 12 consecutive month ) undergo successful surgical sterilization ( hysterectomy , bilateral tubal ligation , bilateral oophorectomy ) . Have sign informed consent approve Institutional Review Board Independent Ethics Committee . Corneal refractive surgery within 6 month study . Current use Restasis Intraocular surgery within 6 month ocular laser surgery within 6 month . Pregnant lactating woman . Ocular pathology ( include glaucoma cataract ) , could impact result and/or place patient risk . Systemic injected corticosteroid ( include oral , parenteral , intravenous , rectal ) 30 day ; Nasal inhale ocular corticosteroid 14 day ; Nasal inhale ipratropium bromide ( atropine ) , inhaled nedocromil , nasal , inhale , ophthalmic sodium cromolyn 14 day ; Agents antihistaminic/anticholinergic activity ( e.g . antidepressant , antipsychotic ) 14 day ; Leukotriene pathway modifier ( Accolate , Singulair , Zyflo ) 10 day ; Ocular antiallergy medication include lodoxamide ( Alomide ) , olopatadine ( Patanol/Pataday ) , emedastine difumarate ( Emadine ) , epinastine ( Elestat ) , levocabastine ( Livostin ) 7 day ; Nonsteroidal antiinflammatory ophthalmics include bromfenac ( Xibrom ) , ketorolac ( Acular/Acuvail ) , nepafenac ( Nevanac ) , flurbiprofen ( Ocufen ) , suprofen ( Profenal ) , diclofenac ( Voltaren ) 7 day ; OTC ophthalmic decongestant , antihistamine , decongestant/antihistamine combination 3 day ; Other anticholinergic agent 3 day Immunotherapy injection 1 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Allergic conjunctivitis</keyword>
</DOC>